Nuzum Charles Lee Sr - Net Worth and Insider Trading

Nuzum Charles Lee Sr Net Worth

The estimated net worth of Nuzum Charles Lee Sr is at least $27,640 dollars as of 2024-04-19. Nuzum Charles Lee Sr is the Director of Predictive Oncology Inc and owns about 24,033 shares of Predictive Oncology Inc (POAI) stock worth over $27,640. Details can be seen in Nuzum Charles Lee Sr's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Nuzum Charles Lee Sr has not made any transactions after 2023-09-25 and currently still holds the listed stock(s).

Transaction Summary of Nuzum Charles Lee Sr

To

Nuzum Charles Lee Sr Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Nuzum Charles Lee Sr owns 1 companies in total, including Predictive Oncology Inc (POAI) .

Click here to see the complete history of Nuzum Charles Lee Sr’s form 4 insider trades.

Insider Ownership Summary of Nuzum Charles Lee Sr

Ticker Comapny Transaction Date Type of Owner
POAI Predictive Oncology Inc 2023-09-25 director

Nuzum Charles Lee Sr Latest Holdings Summary

Nuzum Charles Lee Sr currently owns a total of 1 stock. Nuzum Charles Lee Sr owns 24,033 shares of Predictive Oncology Inc (POAI) as of September 25, 2023, with a value of $27,640.

Latest Holdings of Nuzum Charles Lee Sr

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
POAI Predictive Oncology Inc 2023-09-25 24,033 1.15 27,640

Holding Weightings of Nuzum Charles Lee Sr


Nuzum Charles Lee Sr Form 4 Trading Tracker

According to the SEC Form 4 filings, Nuzum Charles Lee Sr has made a total of 2 transactions in Predictive Oncology Inc (POAI) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Predictive Oncology Inc is the sale of 10,000 shares on September 25, 2023, which brought Nuzum Charles Lee Sr around $30,400.

Insider Trading History of Nuzum Charles Lee Sr

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Nuzum Charles Lee Sr Trading Performance

GuruFocus tracks the stock performance after each of Nuzum Charles Lee Sr's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Nuzum Charles Lee Sr is 54.07%. GuruFocus also compares Nuzum Charles Lee Sr's trading performance to market benchmark return within the same time period. The performance of stocks bought by Nuzum Charles Lee Sr within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Nuzum Charles Lee Sr's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Nuzum Charles Lee Sr

Average Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 23.52 54.07 11.11 -42.22
Relative Return to S&P 500(%) 29.33 45.69 9.47 -49.67

Nuzum Charles Lee Sr Ownership Network

Ownership Network List of Nuzum Charles Lee Sr

No Data

Ownership Network Relation of Nuzum Charles Lee Sr


Nuzum Charles Lee Sr Owned Company Details

What does Predictive Oncology Inc do?

Who are the key executives at Predictive Oncology Inc?

Nuzum Charles Lee Sr is the director of Predictive Oncology Inc. Other key executives at Predictive Oncology Inc include CHIEF FINANCIAL OFFICER Robert L Myers , Chief Business Officer Pamela Bush , and 10 percent owner Carl I. Schwartz .

Predictive Oncology Inc (POAI) Insider Trades Summary

Over the past 18 months, Nuzum Charles Lee Sr made 1 insider transaction in Predictive Oncology Inc (POAI) with a net sale of 10,000. Other recent insider transactions involving Predictive Oncology Inc (POAI) include a net purchase of 16,000 shares made by Daniel E Handley , a net purchase of 8,795 shares made by Robert L Myers , and a net purchase of 5,000 shares made by Raymond F Vennare .

In summary, during the past 3 months, insiders sold 0 shares of Predictive Oncology Inc (POAI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 10,000 shares of Predictive Oncology Inc (POAI) were sold and 1,490 shares were bought by its insiders, resulting in a net sale of 8,510 shares.

Predictive Oncology Inc (POAI)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Predictive Oncology Inc Insider Transactions

No Available Data

Nuzum Charles Lee Sr Mailing Address

Above is the net worth, insider trading, and ownership report for Nuzum Charles Lee Sr. You might contact Nuzum Charles Lee Sr via mailing address: 633 1st Street West, Sonoma Ca 95476.

Discussions on Nuzum Charles Lee Sr

No discussions yet.